Healthcare Economist September 13, 2024
Jason Shafrin

A paper by Qato et al. (2024) quantifies the degree of of pharmacy benefit manager (PBM) market concentration.

Across all payer types, the PBM market was highly concentrated, with an HHI [Herfindahl Hirschman Index (HHI)] of 1972…the HHI was lowest in commercial insurance (1940), with 90 PBM participants, and highest in Medicare Part D (2399), with 21 PBM participants.

Three PBMs dominate in most all markets. In fact, these three large PBMs (CVS Caremark, Optum Rx, and Express Scripts) account for 73.6% of retail prescriptions filled. This does vary...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech
AbbVie to write off $3.5B over failed schizophrenia drug
Drug Price Negotiation Requires Oversight To Protect Older Americans
Major PBMs Inflated Drug Prices, Pocketing $7.3 Billion Along the Way, FTC Says
FTC releases second report slamming pharmacy benefit managers
Lantheus (LNTH) Acquires Life Molecular Imaging for $750M

Share This Article